Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
47.82
+0.49 (1.04%)
At close: Jul 19, 2024, 4:00 PM
49.56
+1.74 (3.64%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

Ionis Pharmaceuticals Revenue

Ionis Pharmaceuticals had revenue of $776.62M in the twelve months ending March 31, 2024, with 34.84% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $119.50M. In the year 2023, Ionis Pharmaceuticals had annual revenue of $787.65M with 34.10% growth.

Revenue (ttm)
$776.62M
Revenue Growth
+34.84%
P/S Ratio
8.99
Revenue / Employee
$837,778
Employees
927
Market Cap
6.98B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023787.65M200.28M34.10%
Dec 31, 2022587.37M-223.09M-27.53%
Dec 31, 2021810.46M81.19M11.13%
Dec 31, 2020729.26M-393.34M-35.04%
Dec 31, 20191.12B522.93M87.20%
Dec 31, 2018599.67M85.50M16.63%
Dec 31, 2017514.18M141.40M37.93%
Dec 31, 2016372.78M89.07M31.40%
Dec 31, 2015283.70M69.54M32.47%
Dec 31, 2014214.16M66.88M45.41%
Dec 31, 2013147.29M45.24M44.33%
Dec 31, 2012102.05M2.96M2.99%
Dec 31, 201199.09M-9.39M-8.65%
Dec 31, 2010108.47M-13.13M-10.80%
Dec 31, 2009121.60M14.41M13.44%
Dec 31, 2008107.19M48.85M83.72%
Dec 31, 200758.34M43.49M292.65%
Dec 31, 200614.86M-25.27M-62.98%
Dec 31, 200540.13M-2.49M-5.84%
Dec 31, 200442.62M-7.37M-14.73%
Dec 31, 200349.99M-30.19M-37.65%
Dec 31, 200280.18M26.91M50.51%
Dec 31, 200153.27M16.02M43.00%
Dec 31, 200037.26M3.33M9.82%
Dec 31, 199933.93M-5.25M-13.39%
Dec 31, 199839.17M6.45M19.71%
Dec 31, 199732.72M10.06M44.39%
Dec 31, 199622.66M6.70M41.94%
Dec 31, 199515.97M454.00K2.93%
Dec 31, 199415.51M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Ensign Group 3.85B
Jazz Pharmaceuticals 3.84B
Exelixis 1.85B
Penumbra 1.10B
Halozyme Therapeutics 862.99M
Repligen 607.45M
Tempus AI 562.02M
Ascendis Pharma 357.63M
Revenue Rankings